Centre of Transplant and Renal Research, Westmead Hospital, Westmead, Australia; Central Clinical School, Faculty of Medicine and Health, University of Sydney, Australia.
Centre of Transplant and Renal Research, Westmead Hospital, Westmead, Australia; Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, 129a Edward Ford Building A27, NSW 2006, Australia; NHMRC Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney, Australia.
J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105730. doi: 10.1016/j.jstrokecerebrovasdis.2021.105730. Epub 2021 Apr 26.
Chronic kidney disease (CKD) is a sustained reduction in estimated glomerular filtration rate (eGFR), and/or presence of albuminuria. People with CKD have adverse cardiovascular outcomes including stroke. CKD and stroke share several risk factors, most notably older age, diabetes and hypertension, but CKD is also an independent risk factor for stroke. Relative burden of increased risk is worse for younger people and women, with <40 years with end stage CKD having more than 11 times the risk of their age-matched peers. Risk also varies by CKD treatment, with a risk peak for those starting dialysis, but dropping after the first month of treatment. Proposed mechanisms for increased risk are uraemia, cerebral blood flow dysregulation, vascular calcification, arterial stiffness, chronic inflammation, vascular access impacts, and for those on haemodialysis the use of anticoagulation to maintain dialysis circuits. Outcomes for people with CKD and stroke are poorer; functional outcomes may be impacted by reduced access to specialised stroke care. Stroke mortality is higher for those with CKD; with standardised mortality ratio more than three times higher than expected, but for some groups higher still (young women <40 years with a kidney transplant have 19 times the risk of stroke mortality than women without a transplant). Interventions to prevent and treat stroke lack the evidence base in CKD patients that is present for the general population.
慢性肾脏病(CKD)是肾小球滤过率(eGFR)持续降低和/或白蛋白尿的存在。患有 CKD 的人有不良的心血管结局,包括中风。CKD 和中风有几个共同的危险因素,最显著的是年龄较大、糖尿病和高血压,但 CKD 也是中风的一个独立危险因素。风险的相对负担对于年轻人和女性来说更严重,患有终末期 CKD 的<40 岁患者的风险是同龄人的 11 倍以上。风险也因 CKD 治疗而异,开始透析的患者风险最高,但在治疗第一个月后下降。增加风险的机制包括尿毒症、脑血流调节异常、血管钙化、动脉僵硬、慢性炎症、血管通路的影响,以及对于接受血液透析的患者,使用抗凝剂来维持透析回路。患有 CKD 和中风的人的结局更差;功能结局可能会受到获得专门的中风治疗的限制。患有 CKD 的中风死亡率更高;标准化死亡率比预期高出三倍以上,但对于某些人群更高(<40 岁的年轻女性接受肾移植的中风死亡率比没有接受移植的女性高 19 倍)。预防和治疗中风的干预措施在 CKD 患者中的证据基础不如普通人群那么充分。